Get insight into the cause of death distribution and epidemiology of penile squamous cell carcinoma: A population-based study.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Author(s): Zhan X;Zhan X; Chen L; Chen L; Jiang M; Jiang M; Fu B; Fu B
  • Source:
    Cancer medicine [Cancer Med] 2022 Jun; Vol. 11 (11), pp. 2308-2319. Date of Electronic Publication: 2022 Mar 03.
  • Publication Type:
    Journal Article; Research Support, Non-U.S. Gov't
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE
    • Publication Information:
      Original Publication: [Malden, MA] : John Wiley & Sons Ltd., c2012-
    • Subject Terms:
      Carcinoma, Squamous Cell* ; Penile Neoplasms*/diagnosis ; Penile Neoplasms*/epidemiology; Cause of Death ; Ethnicity ; Hispanic or Latino ; Humans ; Incidence ; Male ; United States/epidemiology
    • Abstract:
      Background: Penile squamous cell carcinoma (PSCC) survival had no significant improvement since 1990 in the United States. This study aims to get insight into the changing trend and distribution of death causes of PSCC. The epidemiology of PSCC is also investigated.
      Methods: The Surveillance, Epidemiology, and End Results (SEER) (1992-2018) database is utilized to get patients diagnosed with penile squamous cell carcinoma. The trend of incidence, distribution of age, changing trend and distribution of death cause, and survival outcome are analyzed for all PSCC patients and each race.
      Results: Three thousand four hundred and twenty-three male patients with PSCC are enrolled in our study. The age-adjusted incidence rate of the white has a slight increase (Annual percent change [APC] = 0.647%). American Indian/Alaska Native men have the highest average annual incidence, while Asian /Pacific Islander men have the lowest. PSCC patients aged 70-80 are the most common, and patients over 80 years have the highest 3-year (50%) and 5-year (63.93%) mortality rate. Non-cancer disease, especially circulatory system disease, is the most common cause of death, whereas the proportion of patients who died of PSCC significantly increased from 21.17% (1992-2001) to 41.3% (2012-2017) in PSCC patients (p < 0.001). These results have not changed significantly when we only focus on primary PSCC without previous malignant tumors. Hispanics are shown better overall survival than non-Hispanic White and non- Hispanic Black men. (p < 0.001) No statistical differences in cancer-specific survival are observed (p = 0.15).
      Conclusion: The current study provides essential initial data regarding the presentation and clinical outcomes of PSCC patients. Notably, non-cancer disease, especially circulatory system disease, is the more common cause of death than PSCC. However, the proportion of patients who died of penile squamous cell carcinoma has a relatively significant increase in recent years. The increasing trends in the advanced stage of PSCC patients might account for this change.
      (© 2022 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.)
    • References:
      Front Public Health. 2021 Feb 26;9:625778. (PMID: 33718322)
      Eur J Cancer. 2013 Apr;49(6):1414-21. (PMID: 23231984)
      Urol Oncol. 2007 Sep-Oct;25(5):361-7. (PMID: 17826651)
      Eur J Surg Oncol. 2021 Sep;47(9):2286-2294. (PMID: 33632589)
      CA Cancer J Clin. 2018 Jan;68(1):7-30. (PMID: 29313949)
      Dermatol Surg. 2013 Apr;39(4):527-47. (PMID: 23164051)
      Br J Nurs. 2020 May 14;29(9):S6-S14. (PMID: 32407238)
      Cancer. 2008 Nov 15;113(10 Suppl):2883-91. (PMID: 18980292)
      ESMO Open. 2020 Feb;5(1):. (PMID: 32054633)
      BJU Int. 2016 Mar;117(3):439-43. (PMID: 25600638)
      BJU Int. 2016 Feb;117(2):206-7. (PMID: 26750493)
      Transl Androl Urol. 2020 Dec;9(6):3195-3209. (PMID: 33457291)
      CA Cancer J Clin. 2018 Nov;68(6):394-424. (PMID: 30207593)
      Vaccine. 2008 Aug 19;26 Suppl 11:L1-15. (PMID: 18945399)
      Curr Opin Urol. 2020 Mar;30(2):229-233. (PMID: 31972637)
      J Urol. 2012 Sep;188(3):803-8. (PMID: 22818137)
      Eur Urol. 2010 Jun;57(6):1002-12. (PMID: 20163910)
      Urology. 2010 Aug;76(2 Suppl 1):S2-6. (PMID: 20691882)
      Circulation. 2018 Nov 20;138(21):e653-e711. (PMID: 30571578)
      Urol Oncol. 2016 Mar;34(3):122.e9-15. (PMID: 26547834)
      Lancet Infect Dis. 2012 Feb;12(2):142-9. (PMID: 22252147)
      Int J Cancer. 2018 Oct 1;143(7):1569-1577. (PMID: 29667174)
      World J Surg Oncol. 2015 Feb 22;13:71. (PMID: 25889238)
      J Natl Compr Canc Netw. 2013 May 1;11(5):594-615. (PMID: 23667209)
      Minerva Urol Nefrol. 2018 Dec;70(6):559-569. (PMID: 30230297)
      CA Cancer J Clin. 2004 Mar-Apr;54(2):78-93. (PMID: 15061598)
      Cancer Med. 2022 Jun;11(11):2308-2319. (PMID: 35238488)
      Urology. 2016 Apr;90:131-5. (PMID: 26776562)
      BJU Int. 2018 May;121(5):758-763. (PMID: 29281853)
      J Cardiovasc Transl Res. 2020 Feb;13(1):47-54. (PMID: 31044374)
    • Contributed Indexing:
      Keywords: SEER; cause of death; epidemiology; penile squamous cell carcinoma; race; trend
    • Publication Date:
      Date Created: 20220303 Date Completed: 20220603 Latest Revision: 20220823
    • Publication Date:
      20221213
    • Accession Number:
      PMC9160805
    • Accession Number:
      10.1002/cam4.4614
    • Accession Number:
      35238488